Satellite Symposium:
Management of Initial and Recurrent Clostridium difficile Infection: Progress and Promise of Novel Pathways (Not Official IDWeek Programming - Supported by Merck & Co. - See Affiliated Event Guide)
Thursday, October 8, 2015: 6:00 PM-8:00 PM
Room: 30--ABCDE

Learning Objectives:


Erik R. Dubberke, MD, MSPH, FSHEA

Associate Professor of Medicine

Director, Section of Transplant Infectious Diseases

Washington University School of Medicine

St. Louis, Missouri


Stuart J. Johnson, MD

Professor, Department of Medicine

Stritch School of Medicine

Loyola University

Chicago, Illinois


Ciarán P. Kelly, MD

Professor of Medicine

Harvard Medical School

Director Gastroenterology Fellowship Training

Director Celiac Center

Beth Israel Deaconess Medical Center

Boston, Massachusetts


Program Objectives:

Upon completing this activity, participants will be able to:

  • Discuss the interaction between bacteria and host involved in the pathogenesis of Clostridium difficile infection (CDI)
  • Utilize prediction tools that identify pathogen and host factors that contribute to poor clinical outcomes among patients with CDI as a means to guide management approaches
  • Evaluate the role of traditional antimicrobials and newer therapeutic approaches for the treatment of CDI and the prevention of recurrent infection


Accreditation Statement:

Physicians—This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Center designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Pharmacists—Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credits for participating in this activity.


ACPE UAN:  0473-9999-15-003-L01-P                    Activity type: Application-based


Agenda subject to change and was provided by:

Vemco MedEd, LLC; 3322 US Highway 22, Suite 408, Branchburg, NJ 08876; P: (908) 704-2400;



Please contact Maja Drenovac, PharmD at Vemco MedEd directly at (617) 780-9077 for more information.

Target Audience: Infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.